Trial Profile
Efficacy and Safety of entecavir (ETV) in lamivudine resistant patients switched from tenofovir (TDF) for hypophosphatemia or hyperphosphaturia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 17 Dec 2015 New trial record